GlassScriptPhysician profile
Ali Bin Syed
NPI 1851704175
$5,210.46
in general payments reported to CMS, 2019-2025
10 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Pediatric Radiology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.00 · 2022: $374 · 2023: $3,749 · 2024: $659 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396 · Travel and Lodging: $1,629 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.59 |
| Travel and Lodging | $1,629.27 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $2,006.17 | 2023 | Elucirem |
| Boston Scientific Corporation | $1,487.17 | 2022-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Ge Healthcare | $904.21 | 2023-2025 | |
| Abbott Laboratories | $301.86 | 2022-2025 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $188.18 | 2025 | |
| Siemens Medical Solutions USA, INC. | $175.72 | 2023-2024 | Naeotom Alpha |
| Antares Pharma, INC. | $57.79 | 2020-2022 | |
| Rochester Medical Corporation | $44.92 | 2022 | |
| Zimmer Biomet Holdings, INC. | $27.02 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.42 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.